Want to join the conversation?
$PLD 2Q15 PR: Guidance: Prologis increased the midpoint of its FY15 Core FFO guidance and narrowed the range to $2.18-2.22 per diluted share from $2.16-2.22 per diluted share, representing expected YoverY growth of 17% and the company expects to recognize net earnings, for GAAP purposes of $1.12-1.16 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?